Should chemotherapy plus immune checkpoint inhibition be the standard front ‐line therapy for patients with metastatic non–small cell lung cancer?

Cancer, EarlyView.

Source: Cancer - November 1, 2018 Category: Cancer & Oncology Authors: Sarah B. Goldberg, Roy S. Herbst Tags: Insight from the Experts Source Type: research